Disrupting the Kinase–Phosphatase Equilibrium: A Unified Mechanism for Drug-Induced Eryptosis
The advent of targeted cancer therapies has revolutionized oncology, yet the off-target effects of these agents on healthy cells remain a significant clinical challenge. Anemia is one of the most frequent and debilitating adverse effects associated with pharmacological kinase inhibitors, often attributed to bone marrow...